Table 1. 33 TCGA cancer types in which gene expression profiles were analyzed.
| Cancera | Full name | # cancer samples | # normal samples | Stageb | Gradec | ||
|---|---|---|---|---|---|---|---|
| # early-stage | # late- stage | # low-grade | # high- grade | ||||
| BLCA | bladder urothelial carcinoma | 408 | 19 | 132 | 274 | 21 | 384 |
| BRCA | breast invasive carcinoma | 1100 | 112 | 801 | 270 | NA | NA |
| CHOL | cholangiocarcinoma | 36 | 9 | 28 | 8 | 16 | 20 |
| COAD | colon adenocarcinoma | 287 | 41 | 155 | 119 | NA | NA |
| ESCA | esophageal carcinoma | 185 | 11 | 97 | 65 | 95 | 49 |
| GBM | glioblastoma multiforme | 166 | 5 | NA | NA | NA | NA |
| HNSC | head and neck squamous cell carcinoma | 522 | 44 | 118 | 388 | 366 | 132 |
| KICH | kidney chromophobe | 66 | 25 | 46 | 20 | NA | NA |
| KIRC | kidney renal clear cell carcinoma | 534 | 72 | 324 | 207 | 243 | 282 |
| KIRP | kidney renal papillary cell carcinoma | 291 | 32 | 193 | 67 | NA | NA |
| LIHC | liver hepatocellular carcinoma | 373 | 50 | 257 | 90 | 232 | 134 |
| LUAD | lung adenocarcinoma | 517 | 59 | 397 | 110 | NA | NA |
| LUSC | lung squamous cell carcinoma | 501 | 51 | 406 | 91 | NA | NA |
| PRAD | prostate adenocarcinoma | 498 | 52 | NA | NA | NA | NA |
| READ | rectum adenocarcinoma | 95 | 10 | 38 | 46 | NA | NA |
| STAD | stomach adenocarcinoma | 415 | 35 | 180 | 212 | 160 | 246 |
| THCA | thyroid carcinoma | 509 | 59 | 334 | 165 | NA | NA |
| UCEC | uterine corpus endometrial carcinoma | 370 | 11 | 272 | 98 | 185 | 185 |
| ACC | adrenocortical carcinoma | 79 | 0 | 46 | 31 | NA | NA |
| CESC | cervical squamous-cell carcinoma and endocervical adeno-carcinoma | 306 | 3 | 231 | 66 | 153 | 119 |
| DLBC | lymphoid neoplasm diffuse large B-cell lymphoma | 48 | 0 | 25 | 17 | NA | NA |
| LAML | acute myeloid leukemia | 173 | 0 | NA | NA | NA | NA |
| LGG | brain lower-grade glioma | 530 | 0 | NA | NA | 249 | 265 |
| OV | ovarian serous cystadeno-carcinoma | 307 | 0 | 22 | 280 | 34 | 262 |
| PAAD | pancreatic adeno-carcinoma | 179 | 4 | 168 | 8 | 126 | 50 |
| PCPG | pheochromocytoma and paraganglioma | 184 | 3 | NA | NA | NA | NA |
| SARC | sarcoma | 263 | 2 | NA | NA | NA | NA |
| SKCM | skincutaneous melanoma | 472 | 1 | 217 | 193 | NA | NA |
| TGCT | testicular germ-cell tumors | 156 | 0 | 110 | 15 | NA | NA |
| UCS | uterine carcino-sarcoma | 57 | 0 | 27 | 30 | NA | NA |
| UVM | uveal melanoma | 80 | 0 | 36 | 44 | NA | NA |
| MESO | mesothelioma | 87 | 0 | 26 | 61 | NA | NA |
| THYM | thymoma | 120 | 2 | 97 | 21 | NA | NA |
a 18 cancer types are underlined in which gene expression were compared between cancer and normal samples.
b Numbers of early-stage (stage I-II) and late-stage (stage III-IV) cancer samples are shown.
c Numbers of low-grade (G1-2) and high-grade (G3-4) cancer samples are shown.
* “NA” indicates no related information available.